Drug information for CELLCEPT

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 250MG Prescription AB (Reference Drug) MYCOPHENOLATE MOFETIL mycophenolate mofetil ROCHE PALO 50722
2009-11-09 Letter

2009-10-19 Medication Guide

2009-10-14 Label

2009-07-15 Other Important Information from FDA

2009-06-24 Label

2009-06-23 Letter

2009-03-19 Label

2009-03-05 Letter

2009-01-02 Label

2008-12-24 Letter

2008-05-16 Label

2008-05-15 Letter

2008-01-09 Letter

2007-12-27 Label

2007-09-26 Label

2007-09-25 Letter

2005-10-19 Letter

2005-10-19 Label

2004-10-08 Review

2004-10-08 Review

2004-10-08 Review

2003-03-10 Letter

2003-02-28 Label

2000-12-22 Review

2000-12-20 Label

2000-12-20 Letter

2000-07-28 Label

2000-07-28 Letter

2000-07-28 Review
INJECTABLE; INJECTION 500MG/VIAL Prescription  (Reference Drug) MYCOPHENOLATE MOFETIL HYDROCHLORIDE mycophenolate mofetil ROCHE PALO 50758
2009-11-09 Letter

2009-10-19 Medication Guide

2009-10-14 Label

2009-07-15 Other Important Information from FDA

2009-06-24 Label

2009-06-23 Letter

2009-03-19 Label

2009-03-05 Letter

2009-01-02 Label

2008-12-24 Letter

2008-05-16 Label

2008-05-15 Letter

2008-01-09 Letter

2007-12-27 Label

2007-09-26 Label

2007-09-25 Letter

2005-10-19 Label

2005-10-19 Letter

2005-04-19 Letter

2005-04-19 Label

2004-10-08 Review

2003-03-10 Letter

2003-02-28 Label

2000-07-28 Review

2000-07-28 Label

2000-07-28 Letter

1998-08-12 Review
SUSPENSION; ORAL 200MG/ML Prescription  (Reference Drug) MYCOPHENOLATE MOFETIL mycophenolate mofetil ROCHE PALO 50759
2009-11-09 Letter

2009-10-19 Medication Guide

2009-10-14 Label

2009-07-15 Other Important Information from FDA

2009-06-24 Label

2009-06-23 Letter

2009-03-19 Label

2009-03-05 Letter

2009-01-02 Label

2008-12-24 Letter

2008-05-16 Label

2008-05-15 Letter

2008-01-09 Letter

2007-12-27 Label

2007-09-26 Label

2007-09-25 Letter

2005-10-19 Label

2005-10-19 Letter

2005-07-11 Review

2004-10-08 Review

2003-03-10 Letter

2003-02-28 Label

2000-12-22 Review

2000-12-22 Label

2000-12-22 Letter

2000-07-28 Review

2000-07-28 Label

2000-07-28 Letter

1998-10-01 Letter
TABLET; ORAL 500MG Prescription AB (Reference Drug) MYCOPHENOLATE MOFETIL mycophenolate mofetil ROCHE PALO 50723
2009-11-20 Letter

2009-11-09 Letter

2009-10-19 Medication Guide

2009-10-14 Label

2009-07-15 Other Important Information from FDA

2009-06-24 Label

2009-06-23 Letter

2009-03-19 Label

2009-03-05 Letter

2009-01-02 Label

2008-12-24 Letter

2008-05-16 Label

2008-05-15 Letter

2008-01-09 Letter

2007-12-27 Label

2007-09-26 Label

2007-09-25 Letter

2005-10-19 Label

2005-10-19 Letter

2004-10-08 Review

2003-03-10 Letter

2003-02-28 Label

2000-12-22 Review

2000-12-22 Label

2000-12-22 Letter

2000-07-28 Review

2000-07-28 Label

2000-07-28 Letter

Drug Adverse Effects information for CELLCEPT

Role code Indications Reaction # Reports
PS IMMUNOSUPPRESSANT DRUG THERAPY ANXIETY 2
PS IMMUNOSUPPRESSANT DRUG THERAPY BIPOLAR DISORDER 2
PS IMMUNOSUPPRESSANT DRUG THERAPY DEPRESSION 2
PS IMMUNOSUPPRESSANT DRUG THERAPY INSOMNIA 2
PS IMMUNOSUPPRESSION ACNE 6
PS IMMUNOSUPPRESSION CHLOASMA 6
PS IMMUNOSUPPRESSION FUNGAL INFECTION 6
PS IMMUNOSUPPRESSION HIRSUTISM 6
PS IMMUNOSUPPRESSION HYPERTRICHOSIS 6
PS IMMUNOSUPPRESSION PRURIGO 6
PS IMMUNOSUPPRESSION VIRAL INFECTION 6
PS IMMUNOSUPPRESSION XEROSIS 6
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION BLOOD IMMUNOGLOBULIN G DECREASED 6
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION CYTOMEGALOVIRUS TEST POSITIVE 6
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION HALLUCINATION 6
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION HALLUCINATION, AUDITORY 6
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION INFLAMMATION 2
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION UPPER LIMB FRACTURE 6
PS PROPHYLAXIS AGAINST TRANSPLANT REJECTION WHITE BLOOD CELL COUNT DECREASED 6
PS RENAL TRANSPLANT ABDOMINAL PAIN UPPER 1
PS RENAL TRANSPLANT ASTHENIA 1
PS RENAL TRANSPLANT CROHN'S DISEASE 1
PS RENAL TRANSPLANT DIARRHOEA 1
PS RENAL TRANSPLANT ECONOMIC PROBLEM 1
PS RENAL TRANSPLANT EMOTIONAL DISORDER 1
PS RENAL TRANSPLANT QUALITY OF LIFE DECREASED 1
PS SCLERODERMA CONFUSIONAL STATE 1
PS SCLERODERMA CONVULSION 1
PS SCLERODERMA LOSS OF CONSCIOUSNESS 1
SS ACTINIC KERATOSIS SQUAMOUS CELL CARCINOMA OF SKIN 1
SS ANKYLOSING SPONDYLITIS SQUAMOUS CELL CARCINOMA OF SKIN 1
SS BEHCET'S SYNDROME ACCIDENTAL EXPOSURE 14
SS BEHCET'S SYNDROME ANAEMIA 14
SS BEHCET'S SYNDROME MOUTH ULCERATION 14
SS BEHCET'S SYNDROME NAUSEA 14
SS BEHCET'S SYNDROME NEUTROPENIA 14
SS BEHCET'S SYNDROME RASH 14
SS BEHCET'S SYNDROME RENAL FAILURE 14
SS BEHCET'S SYNDROME SQUAMOUS CELL CARCINOMA OF SKIN 39
SS IMMUNODEFICIENCY COMMON VARIABLE SQUAMOUS CELL CARCINOMA OF SKIN 1
SS IMMUNOSUPPRESSANT DRUG THERAPY ANAEMIA 3
SS IMMUNOSUPPRESSANT DRUG THERAPY ASYMPTOMATIC BACTERIURIA 3
SS IMMUNOSUPPRESSANT DRUG THERAPY CYTOMEGALOVIRUS CHORIORETINITIS 3
SS IMMUNOSUPPRESSANT DRUG THERAPY CYTOMEGALOVIRUS INFECTION 3
SS IMMUNOSUPPRESSANT DRUG THERAPY HYPERURICAEMIA 3
SS IMMUNOSUPPRESSANT DRUG THERAPY INFECTION IN AN IMMUNOCOMPROMISED HOST 3
SS IMMUNOSUPPRESSANT DRUG THERAPY MENINGITIS CRYPTOCOCCAL 3
SS IMMUNOSUPPRESSANT DRUG THERAPY NEUROGENIC BLADDER 3
SS IMMUNOSUPPRESSANT DRUG THERAPY NOCARDIOSIS 3
SS IMMUNOSUPPRESSANT DRUG THERAPY ORAL CANDIDIASIS 3
SS IMMUNOSUPPRESSANT DRUG THERAPY OROPHARYNGEAL PAIN 3
SS IMMUNOSUPPRESSANT DRUG THERAPY PROCEDURAL HYPERTENSION 3
SS IMMUNOSUPPRESSANT DRUG THERAPY PYREXIA 3
SS IMMUNOSUPPRESSANT DRUG THERAPY SERRATIA TEST POSITIVE 3
SS IMMUNOSUPPRESSANT DRUG THERAPY UPPER RESPIRATORY TRACT INFLAMMATION 3
SS IMMUNOSUPPRESSANT DRUG THERAPY URINARY TRACT INFECTION 3
SS IMMUNOSUPPRESSANT DRUG THERAPY VIRAL UPPER RESPIRATORY TRACT INFECTION 3
SS PRODUCT USED FOR UNKNOWN INDICATION SQUAMOUS CELL CARCINOMA OF SKIN 13
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION ASTHENIA 4
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION BLOOD IMMUNOGLOBULIN G DECREASED 138
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION CYTOMEGALOVIRUS TEST POSITIVE 138
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION DYSPNOEA 4
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION GASTRITIS 2
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION HALLUCINATION 138
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION HALLUCINATION, AUDITORY 138
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION HYPERKALAEMIA 4
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION HYPOTENSION 4
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION NAUSEA 2
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION UPPER LIMB FRACTURE 138
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION VOMITING 2
SS PROPHYLAXIS AGAINST TRANSPLANT REJECTION WHITE BLOOD CELL COUNT DECREASED 138
SS RENAL TRANSPLANT SKIN CANCER 3
C ACNE CYSTIC BLOOD CHOLESTEROL INCREASED 1
C ACNE CYSTIC BLOOD TRIGLYCERIDES INCREASED 1
C ACNE CYSTIC FEMALE REPRODUCTIVE NEOPLASM 1
C ANALGESIC THERAPY HERPES ZOSTER 2
C ANALGESIC THERAPY NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2
C ANGINA PECTORIS HAEMATOMA 1
C ANGINA PECTORIS MYOCARDIAL INFARCTION 1
C ANTICOAGULANT THERAPY HAEMATOMA 2
C ANTICOAGULANT THERAPY MYOCARDIAL INFARCTION 2
C ARTERIOSCLEROSIS OBLITERANS CONJUNCTIVITIS BACTERIAL 2
C ARTERIOSCLEROSIS OBLITERANS COUGH 1
C ARTERIOSCLEROSIS OBLITERANS DECREASED APPETITE 2
C ARTERIOSCLEROSIS OBLITERANS DEHYDRATION 2
C ARTERIOSCLEROSIS OBLITERANS HAEMODIALYSIS 1
C ARTERIOSCLEROSIS OBLITERANS HAEMOPHILUS INFECTION 1
C ARTERIOSCLEROSIS OBLITERANS INFECTION 2
C ARTERIOSCLEROSIS OBLITERANS PYREXIA 1
C ARTERIOSCLEROSIS OBLITERANS RENAL IMPAIRMENT 2
C ARTERIOSCLEROSIS OBLITERANS TRANSPLANT REJECTION 1
C ARTERIOSCLEROSIS OBLITERANS UPPER RESPIRATORY TRACT INFLAMMATION 1
C ARTHROPATHY HAEMATOMA 3
C ARTHROPATHY MYOCARDIAL INFARCTION 3
C BACK DISORDER HAEMATOMA 1
C BACK DISORDER MYOCARDIAL INFARCTION 1
C BACK PAIN BLOOD AMYLASE INCREASED 1
C BACK PAIN CONDITION AGGRAVATED 1
C BACK PAIN DEHYDRATION 1
C BACK PAIN INTESTINAL OBSTRUCTION 1
C BACK PAIN LIPASE INCREASED 1
C BACK PAIN RENAL FAILURE 1
C BLOOD CHOLESTEROL HAEMATOMA 1
C BLOOD CHOLESTEROL MYOCARDIAL INFARCTION 1
C BLOOD PRESSURE HAEMATOMA 2
C BLOOD PRESSURE MYOCARDIAL INFARCTION 2
C CHEST PAIN HAEMATOMA 1
C CHEST PAIN MYOCARDIAL INFARCTION 1
C COAGULOPATHY HAEMATOMA 2
C COAGULOPATHY MYOCARDIAL INFARCTION 2
C COR PULMONALE CHRONIC CYANOSIS 1
C COR PULMONALE CHRONIC LOSS OF CONSCIOUSNESS 1
C COR PULMONALE CHRONIC SYNCOPE 1
C COR PULMONALE CHRONIC VASODILATATION 1
C CYTOMEGALOVIRUS INFECTION DEATH 1
C DEPRESSION HAEMATOMA 1
C DEPRESSION MYOCARDIAL INFARCTION 1
C DIABETES MELLITUS HAEMATOMA 1
C DIABETES MELLITUS MYOCARDIAL INFARCTION 1
C DIAGNOSTIC PROCEDURE CONJUNCTIVITIS BACTERIAL 1
C DIAGNOSTIC PROCEDURE DECREASED APPETITE 1
C DIAGNOSTIC PROCEDURE DEHYDRATION 1
C DIAGNOSTIC PROCEDURE HAEMODIALYSIS 1
C DIAGNOSTIC PROCEDURE HAEMOPHILUS INFECTION 1
C DIAGNOSTIC PROCEDURE INFECTION 1
C DIAGNOSTIC PROCEDURE PYREXIA 1
C DIAGNOSTIC PROCEDURE RENAL IMPAIRMENT 1
C FABRY'S DISEASE HERPES ZOSTER 2
C FABRY'S DISEASE NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2
C FIBROMYALGIA HAEMATOMA 1
C FIBROMYALGIA MYOCARDIAL INFARCTION 1
C HEPATIC ARTERY STENOSIS DEATH 1
C HISTIOCYTOSIS HAEMATOPHAGIC ARRHYTHMIA 1
C HISTIOCYTOSIS HAEMATOPHAGIC CARDIAC ARREST 1
C HISTIOCYTOSIS HAEMATOPHAGIC CARDIOGENIC SHOCK 1
C HISTIOCYTOSIS HAEMATOPHAGIC CARDIOMYOPATHY 1
C HISTIOCYTOSIS HAEMATOPHAGIC CARDITIS 1
C HISTIOCYTOSIS HAEMATOPHAGIC DISEASE PROGRESSION 1
C HISTIOCYTOSIS HAEMATOPHAGIC MYOCARDIAL INFARCTION 1
C HYPOCALCAEMIA BLOOD SODIUM DECREASED 2
C HYPOCALCAEMIA COMPLICATIONS OF TRANSPLANTED LIVER 2
C HYPOCALCAEMIA HEPATIC NEOPLASM MALIGNANT RECURRENT 2
C HYPOCALCAEMIA HYPERCALCAEMIA 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA EPISTAXIS 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA HAEMATURIA 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA HAEMORRHAGE INTRACRANIAL 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA IDIOPATHIC THROMBOCYTOPENIC PURPURA 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA PHARYNGEAL HAEMORRHAGE 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA SYSTEMIC LUPUS ERYTHEMATOSUS 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA THERAPEUTIC RESPONSE DECREASED 2
C IDIOPATHIC THROMBOCYTOPENIC PURPURA THROMBOCYTOPENIA 2
C IMMUNOSUPPRESSANT DRUG THERAPY CIRCULATORY COLLAPSE 1
C IMMUNOSUPPRESSANT DRUG THERAPY DEPRESSED LEVEL OF CONSCIOUSNESS 1
C IMMUNOSUPPRESSANT DRUG THERAPY INFLUENZA 1
C IMMUNOSUPPRESSANT DRUG THERAPY PNEUMONIA BACTERIAL 1
C IMMUNOSUPPRESSANT DRUG THERAPY SHOCK 1
C IMMUNOSUPPRESSANT DRUG THERAPY SINUS TACHYCARDIA 1
C IRON OVERLOAD BLOOD CREATININE INCREASED 1
C IRON OVERLOAD RENAL IMPAIRMENT 1
C LIVER TRANSPLANT DEATH 1
C MULTIPLE SCLEROSIS CLOSTRIDIAL INFECTION 2
C MULTIPLE SCLEROSIS MULTIPLE SCLEROSIS RELAPSE 2
C MULTIPLE SCLEROSIS URINARY TRACT INFECTION 2
C MUSCLE RELAXANT THERAPY HAEMATOMA 1
C MUSCLE RELAXANT THERAPY MYOCARDIAL INFARCTION 1
C MUSCLE SPASTICITY CLOSTRIDIAL INFECTION 1
C MUSCLE SPASTICITY MULTIPLE SCLEROSIS RELAPSE 1
C MUSCLE SPASTICITY URINARY TRACT INFECTION 1
C NEPHROPATHY HERPES ZOSTER 2
C NEPHROPATHY NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2
C PAIN HAEMATOMA 1
C PAIN MYOCARDIAL INFARCTION 1
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD AMYLASE INCREASED 8
C PRODUCT USED FOR UNKNOWN INDICATION CONDITION AGGRAVATED 8
C PRODUCT USED FOR UNKNOWN INDICATION CORONARY ARTERY BYPASS 5
C PRODUCT USED FOR UNKNOWN INDICATION DEHYDRATION 18
C PRODUCT USED FOR UNKNOWN INDICATION HERPES ZOSTER 2
C PRODUCT USED FOR UNKNOWN INDICATION HIP ARTHROPLASTY 5
C PRODUCT USED FOR UNKNOWN INDICATION INTESTINAL OBSTRUCTION 18
C PRODUCT USED FOR UNKNOWN INDICATION LIPASE INCREASED 8
C PRODUCT USED FOR UNKNOWN INDICATION NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2
C PRODUCT USED FOR UNKNOWN INDICATION PANCREATIC ENZYMES INCREASED 10
C PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE 18
C PRODUCT USED FOR UNKNOWN INDICATION SPINAL CORD COMPRESSION 5
C PROPHYLAXIS ACCIDENTAL OVERDOSE 1
C PROPHYLAXIS NO ADVERSE EVENT 1
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER BLOOD SODIUM DECREASED 1
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER COMPLICATIONS OF TRANSPLANTED LIVER 1
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER HEPATIC NEOPLASM MALIGNANT RECURRENT 1
C PROPHYLAXIS AGAINST GASTROINTESTINAL ULCER HYPERCALCAEMIA 1
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION HERPES ZOSTER 4
C PROPHYLAXIS AGAINST TRANSPLANT REJECTION NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 4
C PULMONARY HYPERTENSION DEATH 1
C RENAL FAILURE CHRONIC ANAEMIA 1
C RENAL FAILURE CHRONIC DRUG INEFFECTIVE 1
C RENAL FAILURE CHRONIC THERAPEUTIC RESPONSE DECREASED 1
C RENAL IMPAIRMENT CONJUNCTIVITIS BACTERIAL 2
C RENAL IMPAIRMENT COUGH 1
C RENAL IMPAIRMENT DECREASED APPETITE 2
C RENAL IMPAIRMENT DEHYDRATION 2
C RENAL IMPAIRMENT HAEMODIALYSIS 1
C RENAL IMPAIRMENT HAEMOPHILUS INFECTION 1
C RENAL IMPAIRMENT INFECTION 2
C RENAL IMPAIRMENT PYREXIA 1
C RENAL IMPAIRMENT RENAL IMPAIRMENT 2
C RENAL IMPAIRMENT TRANSPLANT REJECTION 1
C RENAL IMPAIRMENT UPPER RESPIRATORY TRACT INFLAMMATION 1
C RENAL TRANSPLANT CORONARY ARTERY BYPASS 2
C RENAL TRANSPLANT DRUG INEFFECTIVE 1
C RENAL TRANSPLANT HAEMATOMA 3
C RENAL TRANSPLANT HIP ARTHROPLASTY 2
C RENAL TRANSPLANT MYOCARDIAL INFARCTION 3
C RENAL TRANSPLANT SPINAL CORD COMPRESSION 2
C RHEUMATOID ARTHRITIS ABDOMINAL PAIN 1
C RHEUMATOID ARTHRITIS ARTHRALGIA 2
C RHEUMATOID ARTHRITIS ASTHENIA 1
C RHEUMATOID ARTHRITIS BACK PAIN 1
C RHEUMATOID ARTHRITIS CHEST PAIN 1
C RHEUMATOID ARTHRITIS CONSTIPATION 1
C RHEUMATOID ARTHRITIS DIZZINESS 1
C RHEUMATOID ARTHRITIS DRUG INEFFECTIVE 2
C RHEUMATOID ARTHRITIS DRY MOUTH 1
C RHEUMATOID ARTHRITIS DYSPNOEA 1
C RHEUMATOID ARTHRITIS EYE SWELLING 1
C RHEUMATOID ARTHRITIS HEADACHE 2
C RHEUMATOID ARTHRITIS INSOMNIA 1
C RHEUMATOID ARTHRITIS JOINT SWELLING 1
C RHEUMATOID ARTHRITIS LIBIDO DECREASED 1
C RHEUMATOID ARTHRITIS MUSCLE FATIGUE 1
C RHEUMATOID ARTHRITIS NAUSEA 1
C RHEUMATOID ARTHRITIS OROPHARYNGEAL PAIN 1
C RHEUMATOID ARTHRITIS PAIN 1
C RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS 2
C RHEUMATOID ARTHRITIS SINUSITIS 2
C RHEUMATOID ARTHRITIS SWELLING FACE 1
C RHEUMATOID ARTHRITIS THERAPEUTIC RESPONSE DECREASED 1
C SLEEP DISORDER HAEMATOMA 1
C SLEEP DISORDER MYOCARDIAL INFARCTION 1
C SYSTEMIC LUPUS ERYTHEMATOSUS COUGH 1
C SYSTEMIC LUPUS ERYTHEMATOSUS DRUG INEFFECTIVE 1
C SYSTEMIC LUPUS ERYTHEMATOSUS DYSPEPSIA 1
C SYSTEMIC LUPUS ERYTHEMATOSUS FAECES DISCOLOURED 1
C SYSTEMIC LUPUS ERYTHEMATOSUS FATIGUE 1
C SYSTEMIC LUPUS ERYTHEMATOSUS HEADACHE 2
C SYSTEMIC LUPUS ERYTHEMATOSUS INFLUENZA LIKE ILLNESS 1
C SYSTEMIC LUPUS ERYTHEMATOSUS NAUSEA 2
C SYSTEMIC LUPUS ERYTHEMATOSUS OEDEMA MOUTH 1
C SYSTEMIC LUPUS ERYTHEMATOSUS OROPHARYNGEAL BLISTERING 1
C SYSTEMIC LUPUS ERYTHEMATOSUS PAIN 1
C SYSTEMIC LUPUS ERYTHEMATOSUS PHARYNGITIS STREPTOCOCCAL 1
C SYSTEMIC LUPUS ERYTHEMATOSUS PNEUMONIA 1
C SYSTEMIC LUPUS ERYTHEMATOSUS POSTURE ABNORMAL 1
C SYSTEMIC LUPUS ERYTHEMATOSUS PYREXIA 2
C SYSTEMIC LUPUS ERYTHEMATOSUS RHINORRHOEA 1
C SYSTEMIC LUPUS ERYTHEMATOSUS SWOLLEN TONGUE 1
C SYSTEMIC LUPUS ERYTHEMATOSUS TONGUE BLISTERING 1
C TRANSPLANT DEATH 1
C TYPE 2 DIABETES MELLITUS CHOLELITHIASIS 1
C TYPE 2 DIABETES MELLITUS DEHYDRATION 1
C TYPE 2 DIABETES MELLITUS INTESTINAL OBSTRUCTION 1
C TYPE 2 DIABETES MELLITUS PANCREATIC ENZYMES INCREASED 1
C TYPE 2 DIABETES MELLITUS PANCREATITIS 1
C TYPE 2 DIABETES MELLITUS RENAL FAILURE 1
C TYPE 2 DIABETES MELLITUS WEIGHT DECREASED 1
Ads by Google